| pubmed-article:1683840 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C0019588 | lld:lifeskim |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C0055147 | lld:lifeskim |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C0205464 | lld:lifeskim |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
| pubmed-article:1683840 | lifeskim:mentions | umls-concept:C0058895 | lld:lifeskim |
| pubmed-article:1683840 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1683840 | pubmed:dateCreated | 1992-1-10 | lld:pubmed |
| pubmed-article:1683840 | pubmed:abstractText | The peripheral H1-inhibiting effects of cetirizine 10 mg and ebastine 10 mg were compared at the skin level after single oral administration. The study was performed in 9 healthy subjects under double-blind randomized crossover conditions. Both drugs were significantly effective up to 24 h. The suppressive effect of cetirizine was significantly more rapid and more marked. | lld:pubmed |
| pubmed-article:1683840 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1683840 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1683840 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1683840 | pubmed:issn | 0011-9075 | lld:pubmed |
| pubmed-article:1683840 | pubmed:author | pubmed-author:LachapelleJ... | lld:pubmed |
| pubmed-article:1683840 | pubmed:author | pubmed-author:EganR FRF | lld:pubmed |
| pubmed-article:1683840 | pubmed:author | pubmed-author:RihouxJ PJP | lld:pubmed |
| pubmed-article:1683840 | pubmed:author | pubmed-author:RivestJJ | lld:pubmed |
| pubmed-article:1683840 | pubmed:author | pubmed-author:DespontinKK | lld:pubmed |
| pubmed-article:1683840 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1683840 | pubmed:volume | 183 | lld:pubmed |
| pubmed-article:1683840 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1683840 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1683840 | pubmed:pagination | 208-11 | lld:pubmed |
| pubmed-article:1683840 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:meshHeading | pubmed-meshheading:1683840-... | lld:pubmed |
| pubmed-article:1683840 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1683840 | pubmed:articleTitle | Pharmacological modulation by cetirizine and ebastine of the cutaneous reactivity to histamine. | lld:pubmed |
| pubmed-article:1683840 | pubmed:affiliation | Unité de Dermatologie professionnelle et de l'Environnement, UCL 3033, Bruxelles, Belgique. | lld:pubmed |
| pubmed-article:1683840 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1683840 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1683840 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1683840 | lld:pubmed |
